نتایج جستجو برای: Prostatic Neoplasms

تعداد نتایج: 505718  

Journal: :nephro-urology monthly 0
evangelos mazaris urology department, lister hospital, stevenage, united kingdom alexios tsiotras urology department, lister hospital, stevenage, united kingdom; urology department, lister hospital, stevenage, united kingdom. tel: +44-7580348549, fax: +44-1438515601

results like other cancers, prostate cancer is caused by an accumulation of genetic alterations in a cell that drives it to malignant growth. specific genes and gene alterations have been suggested to play a role in its development and progression. aneuploidy, loss of heterozygosity, gene mutations, hypermethylation and inactivation of specific tumour suppressor genes such as gstpi, apc, mdr1, ...

Journal: :iranian journal of pathology 0
maliheh khoddami pediatric pathology research center, shahid beheshti university of medical sciences tehran, iran yassaman khademi apcp, pathobiology laboratory center, tehran, iran maryam kazemi aghdam pediatric pathology research center, shahid beheshti university of medical sciences tehran, iran haleh soltanghoraee apcp, reproductive biotechnology research center, avicenna research institute, acecr, tehran, iran

background: presence of discordance between the gleason score on needle biopsy and the score of radical prostatectomy specimen is common and universal. in this study, we determined the accuracy of gleason grading of biopsies in predicting histological grading of radical prostatectomy specimens and the degree of overgrading and undergrading of prostatic adenocarcinoma in our center, which is one...

Journal: :nephro-urology monthly 0
panagiotis mourmouris department of urology, school of medicine, wo{e~o yoogeouzenslosy{}anog}oovgwmvylonostiuo, greece +30-2108044703, [email protected] eleni efstathiou department of clinical therapeutics / oncology, school of medicine, university of athens, alexandra hospital, greece athanasios papatsoris department of urology, school of medicine, wo{e~o yoogeouzenslosy{}anog}oovgwmvylonostiuo, greece +30-2108044703, [email protected]; department of urology, school of medicine, wo{e~o yoogeouzenslosy{}anog}oovgwmvylonostiuo, greece +30-2108044703, [email protected]

Journal: :acta medica iranica 0
mostafa hosseini department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seyed ahmad seyedalinaghi iranian research center for hiv/aids (ircha), tehran university of medical sciences, tehran, iran. mahmoud mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. willi mcfarland department of epidemiology and biostatistics, university of california, san francisco, usa.

prostate cancer is a major cause of morbidity and mortality in iran, yet there are few studies examining risk factors specific to the iranian context. we conducted a case-control study to explore risk factors for prostate cancer in mazandaran, iran from 2005 to 2008. the cases were 137 men with clinicopathologically confirmed prostate cancer. controls were 137 neighborhood and age match men wit...

2013
Frank Kunath Steffen F Krause Bernd Wullich Peter J Goebell Dirk G Engehausen Maximilian Burger Joerg J Meerpohl Bastian Keck

BACKGROUND Uro-oncological neoplasms have both a high incidence and mortality rate and are therefore a major public health problem. The aim of this study was to evaluate research activity in uro-oncology over the last decade. METHODS We searched MEDLINE and ClinicalTrials.gov systematically for studies on prostatic, urinary bladder, kidney, and testicular neoplasms. The increase in newly publ...

Journal: :nephro-urology monthly 0
mohammadreza nowroozi uro-oncology research center, tehran university of medical sciences, tehran, ir iran mohsen ayati uro-oncology research center, tehran university of medical sciences, tehran, ir iran hassan jamshidian uro-oncology research center, tehran university of medical sciences, tehran, ir iran amir arbab uro-oncology research center, tehran university of medical sciences, tehran, ir iran hamidreza ghorbani uro-oncology research center, tehran university of medical sciences, tehran, ir iran; uro-oncology research center, tehran university of medical sciences, tehran, ir iran. tel/fax: +98-2166903063 erfan amini uro-oncology research center, tehran university of medical sciences, tehran, ir iran

conclusions using tzpsad as an adjunct to psa may improve the specificity of psa in the diagnosis of pca and decrease the number of unnecessary prostatic biopsies in iranian men with serum psa level < 20 ng/ml. results among 1120 men who were eligible for enrolment, prostate cancer was detected in 265 patients. mean serum psa levels were 9.7 ± 4.3 ng/ml and 8.5 ± 3.7 ng/ml in patients with and ...

Journal: :nephro-urology monthly 0
mohammad reza sharif department of pediatrics, kashan university of medical sciences, kashan, ir iran amirreza shaabani department of urology, kashan university of medical sciences, kashan, ir iran hossein mahmoudi department of urology, kashan university of medical sciences, kashan, ir iran hassan nikoueinejad department of nephrology and urology research center, baqiyatallah university of medical sciences, tehran, ir iran; department of nephrology and urology research center, baqiyatallah university of medical sciences, baqiyatallah hospital, mollasadra ave., vanak sq., p.o. box: 19395-5487, tehran, ir iran. tel: +98-2181262073, fax: +98-3615551112 hossein akbari department of biostatistics, kashan university of medical sciences, kashan, ir iran behzad einollahi department of nephrology and urology research center, baqiyatallah university of medical sciences, tehran, ir iran

background: recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. objectives: this study was aimed to determine whether serum vascular endothelial growth factor (vegf) levels would be a prognostic marker or risk assessment factor in patients with prostate cancer and to investigate whether it could differentiate cancerous tissue fro...

2001
Marcus de Medeiros Matsushita Thais Mauad Paulo Hilário Nascimento Saldiva

Neuroendocrine differentiation in prostatic carcinomas generally confers a more aggressive clinical behavior and less favorable prognosis than usual prostatic carcinomas. In this manuscript, we report a case of a 58-year-old man with prostatic carcinoma who died 1 year after initial diagnosis. Autopsy showed a disseminated prostatic carcinoma with neuroendocrine differentiation. There were meta...

Journal: :international journal of preventive medicine 0
pablo fernandez-crehuet serrano jose luis fernandez-crehuet serrano mohamed farouk allam rafael fernandez-crehuet navajas

background: the presence of noncutaneous neoplasms does not seem to increase the risk of cutaneous malignant melanoma; however, it seems to be associated with the development of other hematological, brain, breast, uterine, and prostatic neoplasms. an ecological transversal study was conducted to study the geographic association between cutaneous malignant melanoma and 24 localizations of cancer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید